BioOrbit Raises $13.2 Million in Seed Funding to Advance In-Space Pharmaceutical Manufacturing

Leila Ahmed Europe Legal Chronicle
Tagged:

Wilson Sonsini Goodrich & Rosati has advised BioOrbit. BioOrbit, a company focused on manufacturing pharmaceuticals in space, has completed a $13.2 million (£9.8 million) seed funding…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here